Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

YOU WONT BELIEVE: Teladoc - You Need To See This

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

BetterHelp remains Teladoc’s biggest headache as customers shift toward insurance-covered therapy and provider capacity struggles to keep up.

Teladoc (TDOC) Stock Plummets on Disappointing Q2 Earnings Results

Teladoc stock sinks on disappointing Q2 revenue and future guidance. Here’s why caution is warranted in buying the dip in TDOC shares today.

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

TDOC Stock Pops as Teladoc Teams Up With Walmart

Teladoc stock rallies on an extended partnership with Walmart. But TDOC shares remain unattractive to own at current levels.

Why Teladoc Health (TDOC) Stock Is Trading Higher Wednesday

Shares of Teladoc Health Inc (NYSE:TDOC) are trading higher and trending Wednesday afternoon. Here’s what investors need to know.

Teladoc (TDOC) Shares Climb On Bullish Commentary From Citron Research

Shares of Teladoc Health Inc (NYSE:TDOC) are surging Friday morning after Citron Research posted bullish comments on the telehealth provider, asserting they were “not wrong, just early” on the stock’s potential. The commentary sparked renewed investor interest, pushing the stock higher in early trading.

Teladoc Health Reports Smaller-Than-Expected Q2 Loss, Revenue Tops Estimates

Teladoc Health Inc (NYSE:TDOC) reported second-quarter financial results Tuesday after the bell. Here’s a look at the key highlights from the report.

inkl

Read news from The Economist, FT, and more,
with one subscription

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?

Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well.

Teladoc Health Stock Jumps After Citron Research Calls It A 'Coiled Spring'

Teladoc Health Stock Jumps After Citron Research Calls It A 'Coiled Spring'

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its X account.

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Former short seller Citron Research is growing bullish on Teladoc's growth potential.

2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick

2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick

Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.

Unveiling 8 Analyst Insights On Teladoc Health

Unveiling 8 Analyst Insights On Teladoc Health

Teladoc Health (NYSE:TDOC) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround

2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround

The pandemic triggered a boom in stocks that accommodated physical isolation, convenient access from home and fitness. Many of these stocks hit unbelie

3 Healthcare Stocks Innovating with AI

3 Healthcare Stocks Innovating with AI

As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might find promising potential in fundamentally solid healthcare stocks like Intuitive Surgical (ISRG), Illumina (ILMN), and Teladoc Health (TDOC). Keep reading.

Get all your
news in one place.

100's of premium titles.
One news app.

2 Beaten-Down Growth Stocks With At Least 35% Upside Potential in 2024

While both stocks have fallen significantly from their 52-week highs, there is more upside to come over the longer term.

TDOC Stock Forecast 2025: Can Teladoc Recover from Its Record Lows?

Teladoc Health stock fell to record lows on Wednesday. Can the telehealth stock recover from its slump?

Is This Cathie Wood Stock an Undervalued AI Play?

Teladoc is a beaten-down telehealth stock that trades at a steep discount to consensus analyst estimates in Q1 of 2024.

TDOC Stock: How Low Can This Cathie Wood Favorite Go?

Teladoc Health stock is in the red this year, and is trading near its record lows. How much lower will this Cathie Wood stock go from these levels?

Get all your
news in one place.

100's of premium titles.
One news app.

2 Cathie Wood Picks to Buy on Weakness in Growth Stocks

While many of the growth stocks in Cathie Wood's portfolio have sold off amid the Fed's rate hikes and tough macro environment, Teladoc Health and SoFi look like two stocks worth buying now.

1 Undervalued Stock to Buy Near 52-Week Lows

Pandemic-era favorite Teladoc Health is trading near its 52-week lows. However, a strong growth outlook and attractive valuations make the stock a good buy at these prices.

3 Stocks to Buy From Wednesday’s Bullish Price Surprises

While the S&P 500 and Dow were relatively flat in Wednesday’s trading, there were some very bullish price surprises from some very popular stocks.

The Guardian - UK

Revealed: NHS England chair fixed meeting for client of bank he advised

David Prior helped arrange a meeting between NHSX and the private care company Teladoc, said to be keen to expand in the UK

This Is What Whales Are Betting On Teladoc Health

Someone with a lot of money to spend has taken a bullish stance on Teladoc Health (NYSE:TDOC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Cathie Wood's Funds Deliver Mixed Q3 Results: Ark Founder's Shares Take On Zoom, Roku, Teladoc And Blockchain

Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI World Index but under

Benzinga Before The Bell: Tesla Model Y Delivery Wait Time Shortened In China, Mark Zuckerberg's Sister Emphasizes On Evolution Of Web3, Amazon Succumbs To TikTok Fever And Other Top Financial Stories Thursday, August 18

1 2

People

211,835 stories

Mark Zuckerberg

Kritika SarmahHer

Vitalik Buterin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

British Airways

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

415,432 stories

148,611 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play